We analyse the science and first impressions behind The Ordinary's most anticipated launch, the 'Multi-Peptide + HA Serum with Growth Factors'. Discover if this budget-friendly powerhouse lives up to the hype for tackling wrinkles and fine lines.
US health authorities issue an urgent Class I recall for mislabelled pain relief capsules over fears of a potentially fatal allergic reaction. Here's what you need to know.
Exclusive: A perfect storm of NHS price hikes and soaring demand for the 'miracle' drug tirzepatide triggers a national shortage, leaving thousands of diabetics and weight-loss patients in limbo. Fears grow as stockpiling begins.
The weight loss drug Mounjaro (tirzepatide) is launching in the UK, challenging Ozempic. Experts warn of potential shortages and urge prescriptions for those with clinical need, not casual use.
Former President Trump's proposed tariffs could severely restrict UK supplies and drastically increase prices for diabetes and weight-management medications like Ozempic, Wegovy, and Mounjaro, creating a new healthcare crisis.
The UK's medicines watchdog approves the weight loss injection Mounjaro (tirzepatide), offering a powerful new option in the fight against obesity. Discover its price, how it works, and where to get it.
Eli Lilly suspends shipments of obesity drug Mounjaro to the UK, triggering a major price surge and leaving thousands of patients in limbo amid supply chain restructuring.
Leading veterinary experts sound the alarm as dogs and cats are rushed to clinics after ingesting potent human diabetes and weight-loss medications, prompting a major animal welfare alert.
Global online retailer iHerb has abruptly suspended sales of melatonin supplements to Australian customers following intensified scrutiny from the Therapeutic Goods Administration (TGA). The popular sleep aid, widely used for insomnia and jet lag, now fac
Health Secretary Wes Streeting takes hardline stance in crucial NHS drug pricing negotiations with pharmaceutical giants, demanding better value for taxpayers while facing industry resistance.
A groundbreaking oral weight loss drug, Orforglipron, has demonstrated dramatic results in a recent clinical trial, offering a potential pill-based alternative to popular injectable treatments like Wegovy. The study shows significant weight reduction, spa
The incredible story of exenatide, a diabetes medication developed for dogs, that is now revolutionising human weight loss treatments and reshaping our understanding of obesity.
A potential second Trump presidency could trigger massive price hikes for life-changing diabetes and obesity medications due to proposed import tariffs, putting essential treatments at risk for millions of Britons.
Breakthrough UK study reveals Retatrutide, the new triple-action 'Godzilla' weight loss injection, is dramatically more effective than its predecessors, helping patients lose up to 24% of their body weight in just 48 weeks.
UK health officials issue a critical safety alert for the type 2 diabetes drug Mounjaro (tirzepatide), linking it to severe stomach paralysis and intestinal blockages. Patients are urged to recognise the warning signs.
A massive haul of illegal semaglutide injections has been intercepted at the UK border, as criminals attempt to smuggle counterfeit versions of the 'Hollywood' weight loss drug Mounjaro into the country, posing a severe health risk to the public.
Health Secretary Wes Streeting confronts major pharmaceutical firms, demanding transparency and fair pricing in the NHS's voluntary rebate scheme, which recouped £1.4bn last year.
Groundbreaking research from the University of Edinburgh suggests paracetamol may increase stroke and heart attack risk in those with high blood pressure. Experts urge caution.
Exclusive: A dramatic price war has broken out for 'game-changer' weight loss drugs Wegovy and Mounjaro in the UK, making them more accessible through private providers but raising concerns for the NHS.
Exclusive: UK health experts issue urgent warnings as severe gastrointestinal illnesses linked to popular diabetes-turned-weight-loss drugs Mounjaro and Ozempic surge. Discover the real risks behind the TikTok trend.
The US FDA has issued an urgent recall for shrimp from Thailand after detecting dangerous levels of radioactive caesium-137. Discover the affected brands and potential health risks.
Exclusive investigation reveals the alarming rise of a dangerous online black market for weight-loss jabs like Ozempic in the UK, as desperate patients bypass the NHS. Experts warn of severe health risks and a growing public health emergency.
An explosive investigation reveals how pharmaceutical giant Novartis leveraged a WHO-led initiative to push its expensive cancer drug in Nigeria and Kenya, raising serious ethical concerns about Big Pharma's role in public health.
The soaring cost of Ozempic in the US is making the popular weight-loss treatment inaccessible for many. Discover the reasons behind the price hike and its impact.
Novo Nordisk has announced significant price cuts for its popular weight-loss and diabetes drugs, Ozempic and Wegovy, making them more accessible to patients across the UK.
The cost of diabetes and weight-loss drugs Mounjaro and Ozempic has surged, sparking concerns over affordability and market competition. Experts weigh in on the implications.
Popular diabetes and weight-loss drugs Ozempic and Mounjaro face price hikes as Trump-era tariffs on Chinese imports take effect. Experts warn of potential shortages and financial strain on patients.
Patients relying on Mounjaro for weight loss face financial strain as prices skyrocket. Experts reveal the alarming consequences of this sudden hike.
UK health officials issue urgent warning over counterfeit Ozempic injections linked to severe side effects. Learn how to spot fake weight-loss drugs.
Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.